Literature DB >> 21899991

The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption.

T A Miettinen1, H Gylling, M J Nissinen.   

Abstract

AIMS: To study the whole-body cholesterol metabolism in man, cholesterol synthesis and absorption need to be measured. Because of the complicated methods of the measurements, new approaches were developed including the analysis of serum non-cholesterol sterols. In current lipidologic papers and even in intervention studies, serum non-cholesterol sterols are frequently used as surrogate markers of cholesterol metabolism without any validation to the absolute metabolic variables. The present review compares serum non-cholesterol sterols with absolute measurements of cholesterol synthesis and absorption in published papers to find out whether the serum markers are valid indicators of cholesterol metabolism in various conditions. DATA SYNTHESIS: During statin treatment, during interventions of dietary fat, and in type 2 diabetes the relative and absolute variables of cholesterol synthesis and absorption were frequently but not constantly correlated with each other. In some occasions, especially in subjects with apolipoprotein E3/4 and E4/4 phenotypes, the relative metabolic markers were even more sensitive than the absolute ones to reflect changes in cholesterol metabolism during dietary interventions. Even in general population at very high absorption the homeostasis of cholesterol metabolism is disturbed damaging the validity of the serum markers.
CONCLUSIONS: It is worth using several instead of only one precursor and absorption sterol marker for making conclusions of altered synthesis or absorption of cholesterol, and even then the presence of at least some absolute measurement is valuable. During consumption of plant sterol-enriched diets and in situations of interfered cholesterol homeostasis the relative markers do not adequately reflect cholesterol metabolism. Accordingly, the validity of the relative markers of cholesterol metabolism should not be considered as self-evident.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899991     DOI: 10.1016/j.numecd.2011.05.005

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  26 in total

Review 1.  Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention.

Authors:  Bryan A Smith; Charmaine Wright; Michael Davidson
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

Review 2.  Progress and perspectives in plant sterol and plant stanol research.

Authors:  Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner
Journal:  Nutr Rev       Date:  2018-10-01       Impact factor: 7.110

3.  Isolated Conglutin γ from Lupin, but not Phytate, Lowers Serum Cholesterol Without Influencing Vascular Lesion Development in the ApoE-deficient Mouse Model.

Authors:  Juliane Radtke; Alexandra Schutkowski; Corinna Brandsch; Frank Hirche; Katrin Hasenkopf; Gabriele I Stangl
Journal:  Plant Foods Hum Nutr       Date:  2015-06       Impact factor: 3.921

4.  Plasma noncholesterol sterols as indicators of cholesterol absorption.

Authors:  Scott M Grundy
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

5.  Serum and lipoprotein sitostanol and non-cholesterol sterols after an acute dose of plant stanol ester on its long-term consumption.

Authors:  H Gylling; M Hallikainen; P Simonen; H E Miettinen; M J Nissinen; T A Miettinen
Journal:  Eur J Nutr       Date:  2011-09-23       Impact factor: 5.614

6.  Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations.

Authors:  Niek C A van de Pas; Johan A C Rullmann; Ruud A Woutersen; Ben van Ommen; Ivonne M C M Rietjens; Albert A de Graaf
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-09       Impact factor: 2.745

7.  Phytosterol containing diet increases plasma and whole body concentration of phytosterols in apoE-KO but not in LDLR-KO mice.

Authors:  Valéria Sutti Nunes; Patrícia Miralda Cazita; Sérgio Catanozi; Edna Regina Nakandakare; Eder Carlos Rocha Quintão
Journal:  J Bioenerg Biomembr       Date:  2019-02-09       Impact factor: 2.945

8.  Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.

Authors:  Francesca Zimetti; Stefano De Vuono; Monica Gomaraschi; Maria Pia Adorni; Elda Favari; Nicoletta Ronda; Maria Anastasia Ricci; Fabrizio Veglia; Laura Calabresi; Graziana Lupattelli
Journal:  J Lipid Res       Date:  2017-08-22       Impact factor: 5.922

9.  Plasma oxyphytosterol concentrations are not associated with CVD status in Framingham Offspring Study participants.

Authors:  Sabine Baumgartner; Rouyanne T Ras; Elke A Trautwein; Maurice C J M Konings; Ronald P Mensink; Jogchum Plat
Journal:  J Lipid Res       Date:  2019-08-27       Impact factor: 5.922

Review 10.  Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications.

Authors:  Katriina Nemes; Fredrik Åberg; Helena Gylling; Helena Isoniemi
Journal:  World J Hepatol       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.